Skip to main content

Advertisement

Table 2 Clinical outcomes of immunocompromised patients with RSV infection

From: Burden of severe RSV disease among immunocompromised children and adults: a 10 year retrospective study

Variable, Number; (%) unless indicated otherwise Children (N = 64) Adult (N = 175) p value Total (N = 239)
All-cause admission to hospital
(adults: 5 missing values)
48 (75.0) 107 (62.9) 0.090 155 (66.2)
ARTI-attributable hospital admissiona
(adults: 5 missing values)
31 (48.4) 58 (34.1) 0.050 89 (38.0)
• Length of hospital stay (d) mean (SD)a • 5 (3.5) • 9 (12.0) • < 0.001 • 7 (9.0)
• Admission to the ICUa • 2 (6.5) • 17 (29.3) • 0.014 • 19 (21.3)
• Use of mechanical ventilationa • 1 (3.2) • 13 (22.4) • 0.029 • 14 (15.7)
• Mortality within 30 days of admissiona • 0 • 11 (19.0) • 0.007 • 11 (12.4)
All-cause mortality within 30 days of admission 1 (1.6) 20 (11.4) 0.018 21 (8.8)
LRTI b(adults: 7 missing values) 26 (40.6) 85 (50.6) 0.188 111 (47.8)
RSV-attributable pneumoniab 12 (18.8) 62 (36.9) 0.008 74 (31.9)
• RSV documented from BALb 2 (16.7) 23 (37.1) 0.024 25 (33.8)
• RSV-bacterial co-infection documented from BAL 0 7 (11.3) 0.020 7 (9.5)
  1. aRefers to patients admitted to hospital for an acute-respiratory-tract infection (ARTI)-attributable hospital admission (i.e excluded patients admitted to hospital for other reasons). bRefers to all patients seen in an ambulatory setting or admitted to hospital for their RSV infection or for another reason. BAL: Bonchoalveolar lavage, SD: Standard deviation, LRTI: Lower respiratory tract infection (adults 7 missing values); d: days. RSV-attributable pneumonia (7 missing values)